Mark Nidorf - Search Results

Year	Number of Results
2007	1
2012	1
2013	1
2016	2
2017	1
2018	3
2021	3
2022	1
2024	1

1

Imazio M, Nidorf M. Imazio M, et al. Among authors: nidorf m. Eur Heart J. 2021 Jul 21;42(28):2745-2760. doi: 10.1093/eurheartj/ehab221. Eur Heart J. 2021. PMID: 33961006 Free PMC article. Review.

2

Colchicine: an affordable anti-inflammatory agent for atherosclerosis.

Thompson PL, Nidorf SM. Thompson PL, et al. Among authors: nidorf sm. Curr Opin Lipidol. 2018 Dec;29(6):467-473. doi: 10.1097/MOL.0000000000000552. Curr Opin Lipidol. 2018. PMID: 30320614 Review.

3

Colchicine for prevention of cardiovascular events.

Hemkens LG, Ewald H, Gloy VL, Arpagaus A, Olu KK, Nidorf M, Glinz D, Nordmann AJ, Briel M. Hemkens LG, et al. Among authors: nidorf m. Cochrane Database Syst Rev. 2016 Jan 27;2016(1):CD011047. doi: 10.1002/14651858.CD011047.pub2. Cochrane Database Syst Rev. 2016. PMID: 26816301 Free PMC article. Review.

4

Anti-inflammatory therapy with canakinumab for atherosclerotic disease: lessons from the CANTOS trial.

Thompson PL, Nidorf SM. Thompson PL, et al. Among authors: nidorf sm. J Thorac Dis. 2018 Feb;10(2):695-698. doi: 10.21037/jtd.2018.01.119. J Thorac Dis. 2018. PMID: 29607136 Free PMC article. No abstract available.

5

Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular Disease.

Robinson PC, Terkeltaub R, Pillinger MH, Shah B, Karalis V, Karatza E, Liew D, Imazio M, Cornel JH, Thompson PL, Nidorf M. Robinson PC, et al. Among authors: nidorf m. Am J Med. 2022 Jan;135(1):32-38. doi: 10.1016/j.amjmed.2021.07.025. Epub 2021 Aug 18. Am J Med. 2022. PMID: 34416165 Free PMC article. Review.

6

Targeting the unstable plaque in acute coronary syndromes.

Thompson PL, Nidorf SM, Eikelboom J. Thompson PL, et al. Among authors: nidorf sm. Clin Ther. 2013 Aug;35(8):1099-107. doi: 10.1016/j.clinthera.2013.07.332. Clin Ther. 2013. PMID: 23973042 Review.

7

Colchicine for secondary prevention in coronary disease.

Fiolet ATL, Nidorf SM, Cornel JH; LoDoCo2 Steering Committee. Fiolet ATL, et al. Among authors: nidorf sm. Eur Heart J. 2021 Mar 14;42(11):1060-1061. doi: 10.1093/eurheartj/ehaa974. Eur Heart J. 2021. PMID: 33346343 No abstract available.

8

Cardiovascular effects and safety of long-term colchicine treatment: Cochrane review and meta-analysis.

Hemkens LG, Ewald H, Gloy VL, Arpagaus A, Olu KK, Nidorf M, Glinz D, Nordmann AJ, Briel M. Hemkens LG, et al. Among authors: nidorf m. Heart. 2016 Apr;102(8):590-6. doi: 10.1136/heartjnl-2015-308542. Epub 2016 Feb 1. Heart. 2016. PMID: 26830663 Review.

9

Cost-effectiveness of low-dose colchicine in patients with chronic coronary disease in the netherlands.

Fiolet ATL, Keusters W, Blokzijl J, Nidorf SM, Eikelboom JE, Budgeon CA, Tijssen JGP, Römer T, Westendorp I, Cornel JH, Thompson PL, Frederix GWJ, Mosterd A, de Wit GA. Fiolet ATL, et al. Among authors: nidorf sm. Eur Heart J Qual Care Clin Outcomes. 2024 Mar 14:qcae021. doi: 10.1093/ehjqcco/qcae021. Online ahead of print. Eur Heart J Qual Care Clin Outcomes. 2024. PMID: 38486357

10

Serendipity: How the search for meaning of serum uric acid might lead to the repurposing of an old drug in patients with cardiovascular disease.

Nidorf M, Jelinek M. Nidorf M, et al. Eur J Prev Cardiol. 2018 Feb;25(3):231-232. doi: 10.1177/2047487317749039. Epub 2017 Dec 15. Eur J Prev Cardiol. 2018. PMID: 29243514 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

12 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year